Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Neotrop Entomol ; 41(3): 204-6, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23950044

RESUMEN

Microsatellite primers developed for a given species are sometimes useful for another in the same genus and in other genera within the same family, making possible to search for pre-existing suitable primers in the databanks such as GenBank. We examined whether existing primers developed for Polistes could be used for Polistes satan Bequaert. We tested 50 microsatellite primers from three Polistes species and found that six microsatellite loci show polymorphism in size in P. satan. These six loci were highly polymorphic, having four to 15 alleles in P. satan with an expected heterozygosity of 0.525-0.832. These loci can be used to study parameters concerning genetic relatedness such as social interactions in colonies and genetic conflicts of interest among nestmate individuals.


Asunto(s)
Repeticiones de Microsatélite/genética , Avispas/genética , Animales , Cartilla de ADN , Femenino , Masculino
2.
J Thorac Cardiovasc Surg ; 109(1): 49-57; discussion 57-9, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7815807

RESUMEN

Infection and rejection remain the greatest threats to the survival of pulmonary allograft recipients. Furthermore, a relationship may exist between these events, because the occurrence of one may predispose to the other. By using multivariate analysis for repeated events, we analyzed the risk factors for bacterial, fungal, and viral infection, grade II or greater acute rejection, and death among 239 lung transplant recipients who received 250 allografts between January 1988 and September 1993. A total of 90 deaths, 491 episodes of acute rejection, and 542 infectious episodes occurred during a follow-up of 6 to 71 months. The hazard or risk patterns of death, infection, and rejection each followed an extremely high risk during the first 100 days after transplantation, a second modest risk period at 800 to 1200 days, and a lower constant risk. Infection and graft failure manifested by diffuse alveolar damage were the major causes of early death (< 100 days), whereas infection and chronic rejection were primary causes of later death after pulmonary transplantation. By multivariate analysis, cytomegalovirus mismatching risk for primary infection was the most significant risk factor for death, rejection, and infection. Absence of cytomegalovirus prophylaxis was also a risk factor for early and late death and late infection. Survival of recipients who received cytomegalovirus prophylaxis was significantly improved. Immunosuppression based on cyclosporine versus FK 506 was a risk factor for late death and late infection. Graft failure manifested by diffuse alveolar damage/adult respiratory distress syndrome was a significant risk for death late after transplantation. These data suggest the following: (1) The hazard for death, infection, and rejection after pulmonary transplantation appears biphasic; (2) lower survival is associated with ischemia-reperfusion lung injury represented by diffuse alveolar damage/adult respiratory distress syndrome; (3) cytomegalovirus mismatch, absence of cytomegalovirus prophylaxis, and development of cytomegalovirus disease are significant threats for death, rejection, and infection after pulmonary transplantation; (4) prevention of cytomegalovirus disease should improve survival by decreasing the prevalence of infection and rejection.


Asunto(s)
Rechazo de Injerto , Enfermedades Pulmonares/microbiología , Trasplante de Pulmón/mortalidad , Adolescente , Adulto , Anciano , Antibacterianos/uso terapéutico , Bronquiolitis Obliterante/etiología , Niño , Preescolar , Infecciones por Citomegalovirus/etiología , Infecciones por Citomegalovirus/mortalidad , Infecciones por Citomegalovirus/prevención & control , Femenino , Humanos , Terapia de Inmunosupresión , Lactante , Enfermedades Pulmonares/prevención & control , Enfermedades Pulmonares/virología , Trasplante de Pulmón/efectos adversos , Trasplante de Pulmón/inmunología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Premedicación , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia , Factores de Tiempo
3.
Circulation ; 88(5 Pt 2): II218-23, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8222157

RESUMEN

BACKGROUND: Preoperative hemodynamic support, complex congenital heart disease, and elevated pulmonary vascular resistance present particular challenges for pediatric heart transplantation. This study was performed to identify preoperative factors that influence survival after pediatric heart transplantation over two eras of pediatric heart transplant experience. METHODS AND RESULTS: We retrospectively analyzed demographic, clinical, and hemodynamic data from 67 pediatric patients who underwent heart transplantation between February 1982 and June 1992 and compared survival between two eras (early experience versus late experience). During the early experience (group 1: February 1982 to August 1989), univariate analysis identified congenital heart disease, pretransplant extracorporeal membrane oxygenator (ECMO) support, inotropic and/or ventilatory support (UNOS status I), elevated transpulmonary gradient (at least 15 mm Hg), and elevated pulmonary vascular resistance index (at least 4 Wood units.m2) as preoperative risk factors for early death after pediatric heart transplantation. However, in the late experience (group 2: September 1989 to June 1992), the only risk factor for premature death by univariate analysis was elevated transpulmonary gradient. By multivariate analysis, elevated transpulmonary gradient was the only risk factor for our early, late, and entire experiences. One-year survival after transplantation for congenital heart disease was improved from 46% in group 1 to 73% in group 2 (P < .05). In group 1, only one patient (25%) with pretransplant ECMO support survived 1 year, whereas 66% (four of six) survived more than 1 year in group 2. CONCLUSIONS: Although elevated transpulmonary gradient continues to be a significant risk factor for pediatric heart transplantation, candidates with congenital heart disease, UNOS status I, and pretransplant ECMO support now can be successfully transplanted with reasonable hope for extended survival.


Asunto(s)
Cardiomiopatías/cirugía , Cardiopatías Congénitas/cirugía , Trasplante de Corazón/mortalidad , Cardiomiopatías/epidemiología , Niño , Preescolar , Femenino , Cardiopatías Congénitas/epidemiología , Trasplante de Corazón/estadística & datos numéricos , Humanos , Terapia de Inmunosupresión , Tablas de Vida , Masculino , Análisis Multivariante , Estudios Retrospectivos , Factores de Riesgo , Análisis de Supervivencia
4.
Oral Science International;5(2): 78-84, Japanese Stomatological Society
en Inglés | URUGUAIODONTO | ID: odn-21889

Asunto(s)
Masticación , Saliva
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA